Molecule
Multiple vitamins injection is a prescription medicine indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. It is available as kits. MedsAcross supplies Multiple vitamins injection for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
INFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. The physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy.
Source: US FDA prescribing information
• INFUVITE PEDIATRIC is a combination product that contains the following vitamins: ascorbic acid, vitamin A, vitamin D, thiamine, riboflavin, pyridoxine, niacinamide, dexpanthenol, vitamin E, vitamin K 1, folic acid, biotin, and vitamin B 12. • INFUVITE PEDIATRIC is for administration by intravenous infusion after dilution. • Recommended daily dosage is based on patient’s actual weight: o INFUVITE PEDIATRIC Single Dose: • Weight less than 1 kg: 1.2 mL of Vial 1 and 0.3 mL of Vial 2 • Weight 1 kg to less than 3 kg: 2.6 mL of Vial 1 and 0.65 mL of Vial 2 • Weight 3 kg or greater: 4 mL of Vial 1 and 1 mL of Vial 2 o INFUVITE PEDIATRIC Pharmacy Bulk Package: • Weight less than 1 kg: 1.5 mL of combined content of Vials 1 and 2 • Weight 1 kg to less than 3 kg: 3.25 mL of combined content of Vials 1 and 2 • Weight 3 kg or greater: 5 mL of combined content of Vials 1 and 2.
Source: US FDA prescribing information
INFUVITE PEDIATRIC is contraindicated in patients who have: • An existing hypervitaminosis, or • A history of hypersensitivity to any vitamins or excipients contained in this formulation. • Hypersensitivity to any of vitamins or excipients. • Existing hypervitaminosis
Source: US FDA prescribing information
• Risk of Aluminum Toxicity: For at risk patients (renal failure or those with prolonged therapy), consider periodic monitoring of aluminum levels. • Allergic Reactions: To thiamine may occur. • Hypervitaminosis A: Patients with renal failure or liver disease may be at higher risk. • Decreased Anticoagulant Effect of Warfarin: Monitor INR. • Interferes with Megaloblastic Anemia Diagnosis: Avoid during testing for this disorder. • Risk of Vitamin Deficiencies or Excesses: Monitor blood vitamin concentrations. • False Negative Urine Glucose Tests: Due to vitamin C. • Risk of Vitamin E Toxicity: Additional oral and parenteral vitamin E may result in elevated vitamin E blood concentrations in infants. • Low Vitamin A Levels: Monitor vitamin A levels. • Risk of E-Ferol Syndrome: Due to polysorbates
Source: US FDA prescribing information
The following adverse reactions are discussed in greater detail in other sections of the labeling. • Allergic reactions to thiamine. • Hypervitaminosis A The following adverse reactions have been identified during postapproval use of INFUVITE PEDIATRIC. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Dermatologic: rash, erythema, pruritis CNS: headache, dizziness, agitation, anxiety Ophthalmic: diplopia Adverse reactions have included anaphylaxis, rash, erythema, pruritis, headache, dizziness, agitation, anxiety, diplopia
Source: US FDA prescribing information
A number of interactions between vitamins and drugs have been reported. The following are examples of these types of interactions. Effect of INFUVITE PEDIATRIC on other drugs: • Antibiotics: Thiamine, riboflavin, pyridoxine, niacinamide, and ascorbic acid decrease activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin. • Bleomycin: Ascorbic acid and riboflavin may reduce the activity of bleomycin. • Levodopa: Pyridoxine may decrease blood levels of levodopa and levodopa efficacy may decrease. • Phenytoin: Folic acid may decrease phenytoin blood levels and increase risk of seizure activity. • Methotrexate: Folic acid may decrease response to methotrexate. Effects of other drugs on INFUVITE PEDIATRIC: • Hydralazine, Isoniazid: Concomitant administration of hydralazine or isoniazid may increase pyridoxine requirements.
Source: US FDA prescribing information
Store under refrigeration 2°C to 8°C (36°F to 46°F).
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
2 presentations of Multiple vitamins injection, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Infuvite Adult kit Cold chain | Sandoz | US FDA | Available on request |
| Infuvite Pediatric kit Cold chain | Sandoz | US FDA | Available on request |
2 brand names across 1 markets.
United States
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | Not recorded | — |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Yes, on request. MedsAcross lists 2 presentations of Multiple vitamins injection and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 2 brand names for Multiple vitamins injection, including Infuvite Adult, Infuvite Pediatric.
At least one listed presentation of Multiple vitamins injection must be kept cold, so it is shipped in temperature-controlled packaging. Check the storage line on each presentation.
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.